AmorChem collects $44.2 mln for second fund
Montreal-based AmorChem, a life sciences venture firm, has raised $44.2 million for its second fund. AmorChem II will focus on backing "promising" life science projects originating from Québec-based universities and research centers. The fund's limited partners include the Québec government, Fonds de solidarité FTQ and Merck.
6 December 2017•4 mins read
